StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Integrated BioPharma's total debt was $18.00K at Mar 31, 2024. For fiscal 2023 it was $49.00K, down 42.4% from the year before. Over ten years it grew -37.9% a year on average. The highest annual figure on record is $6.19M in fiscal 2012.

Annual total debt

PeriodPeriod endValueChange
FY2023Jun 30, 2023$49.00K-42.4%
FY2022Jun 30, 2022$85.00K-94.2%
FY2021Jun 30, 2021$1.46M-65.8%
FY2020Jun 30, 2020$4.26M+13.0%
FY2019Jun 30, 2019$3.77M-14.3%
FY2018Jun 30, 2018$4.40M-18.0%
FY2017Jun 30, 2017$5.36M-12.6%
FY2016Jun 30, 2016$6.14M+31.7%
FY2015Jun 30, 2015$4.66M-5.8%
FY2014Jun 30, 2014$4.95M-14.1%
FY2013Jun 30, 2013$5.76M-7.1%
FY2012Jun 30, 2012$6.19M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2024CQ1 2024Mar 31, 2024$18.00K-77.8%
Q4 FY2023CQ2 2023Jun 30, 2023$49.00K-42.4%
Q3 FY2023CQ1 2023Mar 31, 2023$60.00K–
Q2 FY2023CQ4 2022Dec 31, 2022$70.00K+483.3%
Q1 FY2023CQ3 2022Sep 30, 2022$81.00K-40.4%
Q4 FY2022CQ2 2022Jun 30, 2022$85.00K-94.2%
Q3 FY2022CQ1 2022Mar 31, 2022$0-100.0%
Q2 FY2022CQ4 2021Dec 31, 2021$12.00K-99.6%
Q1 FY2022CQ3 2021Sep 30, 2021$136.00K-96.1%
Q4 FY2021CQ2 2021Jun 30, 2021$1.46M-65.8%
Q3 FY2021CQ1 2021Mar 31, 2021$3.21M+14.8%
Q2 FY2021CQ4 2020Dec 31, 2020$3.33M+9.0%
Q1 FY2021CQ3 2020Sep 30, 2020$3.49M+8.0%
Q4 FY2020CQ2 2020Jun 30, 2020$4.26M+13.0%
Q3 FY2020CQ1 2020Mar 31, 2020$2.80M-30.1%
Q2 FY2020CQ4 2019Dec 31, 2019$3.05M-23.4%
Q1 FY2020CQ3 2019Sep 30, 2019$3.23M-22.5%
Q4 FY2019CQ2 2019Jun 30, 2019$3.77M-14.3%
Q3 FY2019CQ1 2019Mar 31, 2019$4.00M-12.6%
Q2 FY2019CQ4 2018Dec 31, 2018$3.98M-16.2%
Q1 FY2019CQ3 2018Sep 30, 2018$4.17M-13.1%
Q4 FY2018CQ2 2018Jun 30, 2018$4.40M-18.0%
Q3 FY2018CQ1 2018Mar 31, 2018$4.58M-18.8%
Q2 FY2018CQ4 2017Dec 31, 2017$4.75M-15.9%
Q1 FY2018CQ3 2017Sep 30, 2017$4.80M-17.7%
Q4 FY2017CQ2 2017Jun 30, 2017$5.36M–
Q3 FY2017CQ1 2017Mar 31, 2017$5.64M–
Q2 FY2017CQ4 2016Dec 31, 2016$5.65M–
Q1 FY2017CQ3 2016Sep 30, 2016$5.83M–

More Integrated BioPharma figures

See a number that looks wrong?